Nanoparticles that inhibit TRPA1 show significant potential as cancer treatments, especially for cancers overexpressing TRPA1, thus providing a promising approach for overcoming existing chemotherapy resistance (Figure 2b). The gene discussed is TRPA1; the disease is cancer.